1. Asplund K, Tuomilehto J, Stegmayr B, Wester PO, Tunstall-Pedoe H (1988) Diagnostic criteria and quality control of the registration of stroke events in the MONICA Project. Acta Med Scand (Suppl) 728:26–39
2. Brott T, Haley C, Levy D, Barsan B, Sheppard G, Broderick J, Rea R, Marler J (1990) Safety and potential efficacy of tissue plasminogen activator (tPA) for stroke. Stroke 21:181 (abstract)
3. BW-tPA Acute Stroke Study Group (1989) An open multicenter trial of rt-PA in acute stroke. Abstracts from the 1st International Congress, 15–19 Oct 1989, Kyoto, (abstract no PS-12–17)
4. Califf RM, O’Neil W, Stack RS, Aronson L, Mark DB, Mantell S, Geonge BS, Candel RJ, Kereiakes DJ, Abbottsmith C, Topol EJ (1988) Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med 108: 658–662
5. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen L, Dalen J, Dodge H, Francis CK, Hillis D, Ludbrook P, Markis JE, Mueller H, Passamaui ER, Powers ER, Rao AK, Robertson T, Ross P, Ryan TJ, Sobel BE, Willerson J, William DO, Zaret BL, Braumuald E (1987) Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 76:142–154